Marianne Schmid1, H Abraham Chiang2, Akshay Sood3, Logan Campbell3, Felix K-H Chun4, Deepansh Dalela3, James Okwara2, Jesse D Sammon3, Adam S Kibel2, Mani Menon3, Margit Fisch4, Quoc-Dien Trinh2. 1. Center for Surgery and Public Health and Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: dr.marianne.schmid@gmail.com. 2. Center for Surgery and Public Health and Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. 3. Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI. 4. Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Abstract
OBJECTIVES: The Hospital Readmissions Reduction Program mandates reimbursement reductions to hospitals with higher than expected rates of readmissions. We examine causes and predictors of readmissions following major procedures in urologic oncology. MATERIALS AND METHODS: Using the American College of Surgeons National Surgical Quality Improvement Program database, patients undergoing radical prostatectomy (RP), radical (RN) or partial nephrectomy (PN), and radical cystectomy (RC) during the year 2012 were abstracted. Rates of unplanned readmission within 30 days after surgery, as well as causes of readmission, were identified. Multivariable logistic regression models were fitted to examine the association between patient perioperative factors and odds of readmission. RESULTS: Overall, we observed a 5.5% unplanned 30-day readmission rate. Readmission rates for patients treated with RP, RN, PN, and RC were 4.1%, 5.2%, 4.5%, and 15.9%, respectively. For each procedure, approximately two-third of readmissions occurred within the first 10 days following hospital discharge. Commonest causes of readmission after RP included thromboembolic (13.6%), wound (12.2%), renal/genitourinary (12.2%), and gastrointestinal (11.8%); after RN, wound (12.9%) and gastrointestinal (12.9%); after PN, renal/genitourinary (19.6%), cardiovascular (9.8%), and bleeding/hematoma (9.8%); and after RC, renal/genitourinary (15.5%), wound (14.8%), and sepsis/infection (14.1%). RC was significantly associated with readmission. Patients undergoing open RP or PN were more likely to be readmitted relative to their minimally invasive counterparts (odds ratio = 1.53, 95% CI: 1.12-2.08, P = 0.007 and odds ratio = 2.51, 95% CI: 1.38-4.55, P = 0.003, respectively). CONCLUSIONS: Readmissions are relatively common following major urologic oncology procedures. Compared with RP, RN, or PN, RC patients experience the highest burden of readmission. Venous thromboembolism is a common modifiable cause of readmission following urologic cancer surgery. Minimally invasive approach is associated with decreased odds of readmission following RP and PN.
OBJECTIVES: The Hospital Readmissions Reduction Program mandates reimbursement reductions to hospitals with higher than expected rates of readmissions. We examine causes and predictors of readmissions following major procedures in urologic oncology. MATERIALS AND METHODS: Using the American College of Surgeons National Surgical Quality Improvement Program database, patients undergoing radical prostatectomy (RP), radical (RN) or partial nephrectomy (PN), and radical cystectomy (RC) during the year 2012 were abstracted. Rates of unplanned readmission within 30 days after surgery, as well as causes of readmission, were identified. Multivariable logistic regression models were fitted to examine the association between patient perioperative factors and odds of readmission. RESULTS: Overall, we observed a 5.5% unplanned 30-day readmission rate. Readmission rates for patients treated with RP, RN, PN, and RC were 4.1%, 5.2%, 4.5%, and 15.9%, respectively. For each procedure, approximately two-third of readmissions occurred within the first 10 days following hospital discharge. Commonest causes of readmission after RP included thromboembolic (13.6%), wound (12.2%), renal/genitourinary (12.2%), and gastrointestinal (11.8%); after RN, wound (12.9%) and gastrointestinal (12.9%); after PN, renal/genitourinary (19.6%), cardiovascular (9.8%), and bleeding/hematoma (9.8%); and after RC, renal/genitourinary (15.5%), wound (14.8%), and sepsis/infection (14.1%). RC was significantly associated with readmission. Patients undergoing open RP or PN were more likely to be readmitted relative to their minimally invasive counterparts (odds ratio = 1.53, 95% CI: 1.12-2.08, P = 0.007 and odds ratio = 2.51, 95% CI: 1.38-4.55, P = 0.003, respectively). CONCLUSIONS: Readmissions are relatively common following major urologic oncology procedures. Compared with RP, RN, or PN, RC patients experience the highest burden of readmission. Venous thromboembolism is a common modifiable cause of readmission following urologic cancer surgery. Minimally invasive approach is associated with decreased odds of readmission following RP and PN.
Authors: Hanan Goldberg; Chen Shenhar; Hadar Tamir; Roy Mano; Jack Baniel; David Margel; Daniel Kedar; David Lifshitz; Ofer Yossepowitch Journal: World J Urol Date: 2018-09-15 Impact factor: 4.226
Authors: Ahmed R El-Nahas; Diaa-Eldin Taha; Mohamed M Elsaadany; Mohamed H Zahran; Mohamed Hassan; Khaled Z Sheir Journal: Urolithiasis Date: 2017-05-29 Impact factor: 3.436
Authors: Deborah R Kaye; John Syrjamaki; Chad Ellimoottil; Edward W Schervish; M Hugh Solomon; Susan Linsell; James E Montie; David C Miller; James M Dupree Journal: Urology Date: 2017-11-16 Impact factor: 2.649
Authors: Donald E Fry; Michael Pine; Susan M Nedza; David G Locke; Agnes M Reband; Gregory Pine Journal: Medicine (Baltimore) Date: 2016-09 Impact factor: 1.889
Authors: Martijn Boon; Chris Martini; H Keri Yang; Shuvayu S Sen; Rob Bevers; Michiel Warlé; Leon Aarts; Marieke Niesters; Albert Dahan Journal: PLoS One Date: 2018-05-23 Impact factor: 3.240
Authors: Julio T Chong; David Paulucci; Marc Lubin; Alp Tuna Beksac; Greg Gin; John P Sfakianos; Ketan K Badani Journal: Ther Adv Urol Date: 2018-11-09
Authors: Jennifer L Saluk; Robert H Blackwell; William S Gange; Matthew A C Zapf; Anai N Kothari; Paul C Kuo; Marcus L Quek; Robert C Flanigan; Gopal N Gupta Journal: Curr Urol Date: 2018-06-30